Endoscopic fundoplication: An alternative to surgery for GERD

Acid reflux can cause heartburn, oesophagitis and complications such as strictures, while longstanding reflux may increase Barrett’s oesophagus risk. Symptoms alone do not always confirm GERD, particularly when treatment has not helped.

In Australia, proton pump inhibitors (PPIs) are widely prescribed through GPs, hospitals and pharmacies. Some people remain symptomatic, dislike long-term medication or cannot sustain treatment, prompting consideration of a procedure.

Endoscopic fundoplication strengthens the anti-reflux barrier without external abdominal incisions. It is an alternative to surgical fundoplication, but reflux evidence, anatomy, prior treatment and local expertise determine whether it is suitable.

When GERD needs a procedural option

Red flags such as difficulty swallowing, gastrointestinal bleeding, unexplained weight loss, persistent vomiting or new symptoms at an older age warrant prompt review. Endoscopy can assess oesophagitis, ulcers, Barrett’s oesophagus and the gastro-oesophageal junction.

When symptoms persist despite suitable PPI therapy, objective testing can distinguish acid reflux from functional heartburn. Ambulatory pH or impedance-pH monitoring and oesophageal manometry identify whether acid, non-acid reflux or impaired motility is driving symptoms, strongly influencing procedure suitability.

How the anti-reflux barrier is rebuilt

Endoscopic fundoplication differs from radiofrequency ablation because it reconstructs a valve at the gastro-oesophageal junction. In transoral incisionless fundoplication (TIF), a device such as EsophyX places synthetic fasteners to create a short flap, restoring the lower oesophageal sphincter (LES) barrier without abdominal incisions.

Trials generally show improved symptoms, lower acid exposure and reduced PPI use in selected patients. It may recover sooner than laparoscopic fundoplication, but durability and re-intervention need discussion. ISDE 2021 also explores oesophageal tissue engineering, aimed at replacing damaged tissue rather than tightening the barrier; it remains experimental for GERD.

Choosing suitable patients

Candidates usually have documented reflux, troublesome symptoms despite medication and anatomy that permits safe device placement. Large hiatus or hiatal hernias, severe dysmotility, active inflammation, significant dysphagia or previous oesophageal or gastric surgery may reduce suitability.

Assessment usually includes gastroenterology review, endoscopy, pH testing when appropriate and manometry. Pregnancy, obesity, medication effects and conditions such as Zollinger-Ellison syndrome require individual consideration. Benefits should be weighed against device limitations and the likelihood of later surgery.

Procedure, recovery and complications

The procedure usually takes about 30–60 minutes under sedation or anaesthesia, using an endoscope through the mouth. It creates a fundoplication-like valve at the junction; most patients go home the same day, depending on sedation, recovery and local day-surgery policy.

Early effects can include throat soreness, bloating, nausea and temporary dysphagia. Perforation, bleeding, device migration and persistent dysphagia are uncommon but important. Gas-bloat symptoms can occur if the barrier is too tight. Follow-up may include endoscopy and device-position assessment; revision or removal is possible if symptoms recur.

Access and regulation in Australia

Specialist endoscopy is concentrated in Melbourne, Sydney, Brisbane, Adelaide and Perth. People in regional, rural and remote areas may need travel, telehealth and time away from work, while access to proceduralists with endoscopic fundoplication experience may be narrower.

Australia’s public and private systems operate together. Public treatment is generally delivered through Medicare and state services; eligible private-hospital procedures may attract a Medicare Benefits Schedule rebate plus insurer contributions. Costs may include gap payments, device fees, endoscopy and follow-up, making written estimates important.

The Therapeutic Goods Administration regulates medical devices in Australia. Relevant devices generally require inclusion in the Australian Register of Therapeutic Goods, with sponsors responsible for compliance and post-market obligations.

Long-distance driving, shift work, late-night meals and alcohol can compound symptoms in everyday Australian life. Medication changes need clinical advice, and trigger-specific adjustments should complement formal evaluation.

Practical guidance for comparing GERD treatments

No procedure suits everyone with reflux. PPIs remain first-line for many, surgery can provide durable repair in selected anatomy, and endoscopic fundoplication may suit medication-dependent patients seeking a less invasive intervention. LINX uses magnetic beads laparoscopically and has distinct dysphagia and device risks.

• Establish objective reflux evidence and exclude alarm features before discussing any intervention.
• Compare expected symptom relief with recovery, device surveillance and possible re-intervention.
• Request written estimates covering hospital, device, endoscopy and follow-up charges.
• Confirm the operator’s experience, credentialing and arrangements for managing device complications.

The next concrete step is to arrange an appointment with a gastroenterologist to review symptoms, medicines and prior tests, and decide whether endoscopy, reflux monitoring or a discussion of this technique is warranted.